Adebowale Adeniran, MD

Associate Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Anatomic Pathology Elective

Research Interests

Urinary Bladder Neoplasms; Carcinoma, Renal Cell; Kidney Neoplasms; Pathology; Pathology, Surgical; Penile Neoplasms; Prostatic Neoplasms; Testicular Neoplasms; Thyroid Neoplasms; Ureteral Neoplasms; Urethral Neoplasms

Research Organizations

Pathology: Thoracic and Genitourinary Translational Team

Faculty Research

Yale Cancer Center

Office of Cooperative Research

Research Summary

Clinico-pathologic and molecular pathologic aspects of kidney and thyroid cancers.

Specialized Terms: Oncologic Surgical Pathology; Cytopathology; Urologic Pathology.

Extensive Research Description

Biology of translocation renal cell carcinoma; Biology of the papillary thyroid carcinoma

Selected Publications

  • Clear Cell Adenocarcinoma of the Urinary Bladder: A Short Review

    Adeniran A.J, Tamboli P. Clear Cell Adenocarcinoma of the Urinary Bladder: A Short Review. Arch Pathol Lab Med. 2009133:987-91

  • Granular cell tumor of the breast: a series of 17 cases and review of the literature.

    Adeniran A, Al-Ahmadie H, Mahoney M, Robinson-Smith T. Granular Cell Tumor of the Breast: A Series of 17 Cases and Review of the Literature. The Breast Journal. 200410:528-531.

  • Racial disparities in renal cell carcinoma: a single-payer healthcare experience Mafolasire A, Yao X, Nawaf C, Suarez-Sarmiento A, Chow WH, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B. Cancer Med. 2016;5:2101-2108.
  • Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection: Literature Review and Insights. Peterss S, Mansour AM, Ross JA, Vaitkeviciute I, Charilaou P, Dumfarth J, Fang H, Ziganshin BA, Rizzo JA, Adeniran AJ, Elefteriades JA. Am Coll Cardiol. 2016;68:1054-65.
  • Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. Proc Natl Acad Sci U S A. 2016;113:2170-5.
  • Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic and Genetic Features. Adeniran AJ, Shuch B, Humphrey PA. Am J Surg Pathol. 2015;39:e1-e18.
  • Adenocarcinoma of the Urinary bladder arising in a diverticulum. Fu L, Humphrey PA, Adeniran AJ. J Urol. 2015;194:527-8
  • MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors. Shuch B, Falbo R, Parisi F, Adeniran AJ, Kluger Y, Kluger HM, Jilaveanu L. Biomed Res. Int. 2015;2015:192406.
  • Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens. Baine MK, Turcu G, Zito CR, Adeniran AJ, Camp RL, Chen L, Kluger HM, Jilaveanu LB. Oncotarget. 2015;6:24990-5002.
  • Clinicopathological and Immunohistochemical Characteristics of Papillary Renal Cell Carcinoma with Emphasis on Subtyping. Alomari A, Nettey OS, Singh D, Kluger HM, Adeniran AJ. Hum Pathol. 2015;46:1418-26.
  • PAX-8 expression in renal tumours and distant sites: A useful marker of primary and metastatic renal cell carcinoma? Barr ML, Jilaveanu LB, Camp RL, Adeniran AJ, Kluger HM, Shuch B. J Clin Pathol. 2015;68:12-7.
  • Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data. Eilers SG, LaPolice P, Mukunyadzi P, Kapur U, Wendel Spiczka A, Shah A, Saleh H, Adeniran A, Nunez A, Balachandran I, Clark JJ, Lemon L. Cancer Cytopathol. 2014;122:745-50.
  • Risk Stratification in Follicular neoplasm using the Modified Bethesda Classification Ustun B, Chhieng D, Holt E, Carling T, Udelsman R, Adeniran AJ. Cancer Cytopathol. 2014;122:536-45.
  • Renal Leiomyoma Fu L, Humphrey PA, Adeniran AJ. J Urol. 2015;193:997-8.
  • Best practice of BRAF V600E mutation testing for the diagnosis and management of thyroid cancers. Adeniran AJ, Hui P. Expert Rev Endocrinol Metab. November 2014;9:571-577
  • Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA diagnosis and Implications for Patient Management. Ustun B, Chhieng D, Prasad M, Holt E, Udelsman R, Schofield K, Adeniran AJ. Endocr Pathol. 2014;25:257-64.
  • Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC. Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC. Thyroid 2011;21: 717-23
  • Correlation Between Genetic alterations and Microscopic Features, Clinical Manifestations, and prognostic characteristics of Papillary Thyroid Carcinomas. Adeniran AJ, Zhu Z, Gandhi M, Steward D.L, Fidler J.P, Giordano T.J, Biddinger P.W, Nikiforov Y.E. Am J Surg Pathol. 2006;30:216-222

Full List of PubMed Publications

Edit this profile

Contact Info

Adebowale Adeniran, MD
Patient Care Location
Yale PathologyYale New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Office Location
Clinic Building
789 Howard Avenue, Ste CB 510A

New Haven, CT 06519
View on map...
Mailing Address
310 Cedar Street
P.O. Box 208023

New Haven, CT 06520-8023